Ulnar Leprosy (Leprosy Affecting the Ulnar Nerve)
Overview
Ulnar leprosy refers to the involvement of the ulnar nerve by Mycobacterium leprae, the bacterium that causes leprosy (also known as Hansen’s disease). The ulnar nerve runs from the neck down the inside of the arm, around the elbow (the “funny bone”), and into the hand, supplying sensation to the little finger and half of the ring finger, as well as motor function to several intrinsic hand muscles.
When the bacterium invades this nerve, it can cause a spectrum of sensory loss, muscle weakness, and deformities that are characteristic of peripheral neuropathy seen in leprosy. Because the ulnar nerve is one of the most commonly affected peripheral nerves in leprosy, recognizing its specific signs is crucial for early diagnosis and prevention of permanent disability.
Who it affects: Leprosy is a disease of low‑to‑middle‑income countries, especially in South‑East Asia, Africa, and the Americas. The World Health Organization (WHO) reported ~ 127,000 new cases worldwide in 2022. Of those, roughly 30‑40 % present with peripheral nerve involvement, and the ulnar nerve is involved in up to 25 % of patients with multibacillary disease (the more severe form) [1].
Prevalence: In endemic regions, up to 5 % of the general population may have been exposed to M. leprae, but only a minority develop clinical disease. In the United States and Europe, leprosy is rare (< 10 cases per year), but clinicians must remain vigilant when patients present with isolated ulnar neuropathy and a history of travel or residence in endemic areas.
Symptoms
The clinical picture depends on the stage of disease (paucibacillary vs. multibacillary) and the degree of nerve damage. Below is a comprehensive list of signs and symptoms specific to ulnar nerve involvement:
Sensory Symptoms
- Loss of tactile sensation over the little finger and the ulnar half of the ring finger.
- Reduced temperature and pain perception in the same distribution, increasing risk of unnoticed injuries.
- Paresthesia – tingling, “pins‑and‑needles,” or burning sensations, often intermittent at first.
- Hyperesthesia – heightened sensitivity to light touch, which can be painful.
Motor Symptoms
- Weakness of intrinsic hand muscles (e.g., interossei, lumbricals) leading to difficulty spreading or closing the fingers.
- Claw hand deformity – hyperextension at the metacarpophalangeal (MCP) joints and flexion at the proximal interphalangeal (PIP) joints of the ring and little fingers.
- Weak wrist flexion and difficulty gripping objects.
- Atrophy of the hypothenar eminence (muscle bulk at the base of the little finger).
Other Neurologic/Physical Findings
- Ulnar nerve thickening palpable at the elbow (cubital tunnel) or wrist.
- Loss of reflexes in the hand (e.g., diminished flexor digitorum profundus reflex).
- Ulceration or trophic changes due to sensory loss—skin breakdown on fingertips, especially if unnoticed injuries occur.
- Secondary infections of ulcers, which can progress to osteomyelitis.
Symptoms typically evolve slowly over months, but once nerve damage occurs, it may become permanent without timely treatment.
Causes and Risk Factors
Primary Cause
Ulnar leprosy is caused by infection with Mycobacterium leprae, an intracellular, acid‑fast bacillus that preferentially infects peripheral nerves and skin. The organism spreads chiefly through prolonged close contact with untreated patients, likely via nasal droplets or skin lesions.
Risk Factors
- Geographic exposure: Living in or traveling to endemic regions (India, Brazil, Indonesia, Bangladesh, Ethiopia, Nigeria).
- Close contact with untreated leprosy patients: Household members, co‑workers, or caregivers.
- Genetic susceptibility: Certain HLA–DR and LRRK2 polymorphisms increase susceptibility to leprosy and nerve involvement [2].
- Immunocompromised state: HIV infection, diabetes, or chronic steroid use can increase risk of multibacillary disease.
- Poor socioeconomic conditions: Overcrowding, limited access to health care, and malnutrition.
- Occupational exposure: Healthcare workers, textile workers, and those handling animal hides in endemic areas.
Diagnosis
Diagnosing ulnar leprosy requires a combination of clinical suspicion, neurological examination, and laboratory testing.
Clinical Evaluation
- Detailed history of residence/travel, contact with known leprosy patients, and symptom chronology.
- Focused neurological exam documenting sensory loss, muscle weakness, and any palpable nerve thickening.
Laboratory & Imaging Tests
- Skin slit‑smear microscopy – Ziehl‑Neelsen or Fite‑Faraco staining to detect acid‑fast bacilli; useful in multibacillary disease.
- Skin or nerve biopsy – Histopathology shows granulomas with or without acid‑fast bacilli; PCR can confirm M. leprae DNA.
- Serologic tests – Anti‑phenolic glycolipid‑1 (PGL‑1) antibodies are supportive but not definitive.
- Electrophysiological studies – Nerve conduction velocity (NCV) testing demonstrates slowed conduction across the ulnar nerve, confirming neuropathy.
- High‑resolution ultrasonography – Visualizes nerve thickening and can guide biopsy.
Classification
Leprosy is classified based on bacterial load and clinical presentation:
- Paucibacillary (PB): ≤5 skin lesions, negative smear, often limited nerve involvement.
- Multibacillary (MB): >5 lesions, positive smear, higher risk of extensive nerve damage, including the ulnar nerve.
Correct classification determines the length of multidrug therapy (MDT).
Treatment Options
Multidrug Therapy (MDT)
The WHO recommends standardized MDT for all forms of leprosy. The regimen includes:
| Form | Drugs (monthly dose) | Duration |
|---|---|---|
| Paucibacillary | Dapsone 100 mg + Rifampicin 600 mg | 6 months |
| Multibacillary | Dapsone 100 mg + Rifampicin 600 mg + Clofazimine 300 mg | 12 months |
MDT stops bacterial replication, halts disease progression, and reduces transmission [3].
Adjunctive Therapies for Nerve Damage
- Prednisone or other corticosteroids: 1 – 2 mg/kg/day tapered over 12–24 weeks for acute neuritis (inflammation) to reduce edema and prevent permanent damage.
- Thalidomide: Reserved for severe ENL (erythema nodosum leprosum) reactions that can involve nerves.
- Physiotherapy & occupational therapy: Early guided exercises preserve muscle strength and prevent contractures.
- Surgical decompression: For chronic ulnar nerve compression (e.g., cubital tunnel syndrome) when medical therapy fails; involves nerve release or transposition.
Lifestyle & Supportive Measures
- Foot‑ and hand‑care education to avoid injuries.
- Use of protective gloves when handling hot objects or rough materials.
- Regular skin inspection—especially of the fingertips.
- Smoking cessation and optimal glycemic control (if diabetic) to promote nerve healing.
Living with Ulnar Leprosy (Leprosy Affecting the Ulnar Nerve)
Daily Management Tips
- Self‑examination: Check the little and ring fingers daily for cuts, redness, or swelling.
- Protective splinting: Night splints keep the elbow slightly flexed, reducing tension on the ulnar nerve.
- Hand exercises: Gentle finger spreading, “paper‑pinch” grip, and thumb opposition 3–5 times daily.
- Skin hygiene: Keep hands clean and moisturized; apply barrier creams to prevent cracks.
- Prompt wound care: Small abrasions should be cleaned with mild antiseptic and covered with a sterile dressing.
- Regular follow‑up: Attend clinic appointments every 2–3 months during MDT to monitor nerve function.
- Psychosocial support: Join leprosy patient groups; stigma can be a major barrier to adherence.
Assistive Devices
- Adaptive utensils with larger handles.
- Keyboard modifications (e.g., keyguards) for those with severe grip weakness.
- Custom orthotics for the hand if claw deformity progresses.
Prevention
- Early case detection: Community health workers should screen contacts of known leprosy patients.
- Complete MDT for all diagnosed patients: Ensures cure and stops transmission (≥ 95 % cure rate).
- Vaccination research: BCG vaccine offers partial protection; some endemic countries incorporate BCG into neonatal programs.
- Public education: Promote awareness that leprosy is curable and not highly contagious.
- Improved living conditions: Reducing overcrowding and enhancing nutrition decrease susceptibility.
Complications
If ulnar leprosy is not treated promptly, the following complications may arise:
- Permanent sensory loss → repeated injuries, ulcerations, and secondary infections.
- Claw hand deformity leading to loss of fine motor skills, affecting self‑care and employment.
- Secondary osteomyelitis of the phalanges due to chronic ulcers.
- Neuropathic pain which can be severe and difficult to control.
- Psychological impact – social stigma, depression, and reduced quality of life.
- Disability and loss of livelihood: In severe cases, patients may become unable to perform manual labor, leading to economic hardship.
When to Seek Emergency Care
- Rapidly spreading redness, warmth, or swelling of the hand or fingers (possible cellulitis).
- Severe, uncontrolled pain in the ulnar distribution.
- Fever > 38 °C (100.4 °F) with a hand wound – indicates possible systemic infection.
- Sudden loss of hand function (e.g., inability to close fingers) after an injury.
- Signs of septicemia: chills, rapid heartbeat, low blood pressure.
If any of these occur, go to the nearest emergency department or call emergency services right away.
References
- World Health Organization. Leprosy (Hansen’s Disease) Fact Sheet. 2023. https://www.who.int/news-room/fact-sheets/detail/leprosy
- Fabri, M., et al. “Genetic susceptibility to leprosy and its clinical forms.” Journal of Infectious Diseases, vol. 221, no. 11, 2020, pp. 1820‑1828.
- World Health Organization. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy, 2018. https://apps.who.int/iris/handle/10665/272705
- Mayo Clinic. “Leprosy.” 2024. https://www.mayoclinic.org/diseases-conditions/leprosy/symptoms-causes/syc-20354062
- Cleveland Clinic. “Peripheral Neuropathy – Clinical Evaluation.” 2023. https://my.clevelandclinic.org/health/diseases/21225-peripheral-neuropathy